Adamis Pharmaceuticals (ADMP) has had the highest return since May 1, 2023 by a micro-cap US stock, returning 4,221%.
Adamis Pharmaceuticals (ADMP) has had the highest return since May 1, 2023 by a micro-cap US stock, returning 4,221%.
| ASSET | % RETURN |
|---|---|
| Adamis Pharmaceuticals (ADMP) | 4,220.99% |
| Galmed Pharmaceuticals (GLMD) | 1,518.12% |
| Nisun International Enterprise Development (NISN) | 751.92% |
| GSI Technology (GSIT) | 289.61% |
| Corvus Pharmaceuticals (CRVS) | 190% |
| BurgerFi International, LLC (BFIIW) | 161.94% |
| ADS-TEC Energy (ADSE) | 161.3% |
| Minim (MINM) | 152.88% |
| Goldenbridge Acquisition (GBRGW) | 150% |
| Nanobiotix (NBTX) | 128.6% |
| IN8bio (INAB) | 125% |
| Digital Brands (DBGIW) | 122.09% |
| Minerva Neurosciences (NERV) | 115.76% |
| Bellicum Pharmaceuticals (BLCM) | 113.24% |
| ClearOne (CLRO) | 99.22% |
| Whole Earth Brands (FREEW) | 98.71% |
| Oramed Pharmaceuticals (ORMP) | 93.91% |
| Bioventus (BVS) | 93.07% |
| Enveric Biosciences (ENVB) | 92.39% |
| Fujian Blue Hat Interactive Entertainment Technology (BHAT) | 83.57% |
| Apyx Medical (APYX) | 81.98% |
| Ideanomics (IDEX) | 79.69% |
| NantHealth (NH) | 78.52% |
| VivoPower International (VVPR) | 76.87% |
| Trinity Place (TPHS) | 76.42% |
Micro-cap stocks are treated as having a market cap of <= $300M.